TRILEXIUM Trademark

Trademark Overview

On Friday, July 4, 2014, a trademark application was filed for TRILEXIUM with the United States Patent and Trademark Office. The USPTO has given the TRILEXIUM trademark a serial number of 79154821. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, April 22, 2022. This trademark is owned by Novogen Research Pty Ltd. The TRILEXIUM trademark is filed in the Pharmaceutical Products category with the following description:

Anti-cancer pharmaceutical preparations; pharmaceutical preparations for the treatment of cancer; medical therapeutic agents for the treatment of cancer; medical therapeutic drugs for the treatment of cancer
trilexium

General Information

Serial Number79154821
Word MarkTRILEXIUM
Filing DateFriday, July 4, 2014
Status709 - CANCELLED - SECTION 71
Status DateFriday, April 22, 2022
Registration Number4824342
Registration DateTuesday, October 6, 2015
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 21, 2015

Trademark Statements

Goods and ServicesAnti-cancer pharmaceutical preparations; pharmaceutical preparations for the treatment of cancer; medical therapeutic agents for the treatment of cancer; medical therapeutic drugs for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, April 22, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameKazia Research Pty Ltd
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressAU
Party NameNovogen Research Pty Ltd
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressAU
Party NameNovogen Research Pty Ltd
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressAU

Trademark Events

Event DateEvent Description
Tuesday, March 14, 2023TOTAL INVALIDATION PROCESSED BY THE IB
Thursday, February 16, 2023TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Wednesday, February 15, 2023INVALIDATION PROCESSED
Thursday, December 22, 2022TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Sunday, June 19, 2022NEW REPRESENTATIVE AT IB RECEIVED
Friday, April 22, 2022CANCELLED SECTION 71
Tuesday, October 6, 2020COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Thursday, June 13, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, June 13, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, September 14, 2018CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, July 8, 2016FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, May 6, 2016FINAL DISPOSITION NOTICE SENT TO IB
Friday, May 6, 2016FINAL DISPOSITION PROCESSED
Wednesday, January 6, 2016FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, October 6, 2015REGISTERED-PRINCIPAL REGISTER
Tuesday, July 21, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 21, 2015PUBLISHED FOR OPPOSITION
Friday, July 17, 2015NOTIFICATION PROCESSED BY IB
Wednesday, July 1, 2015NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, July 1, 2015NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, July 1, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, June 12, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, June 9, 2015ASSIGNED TO LIE
Wednesday, May 20, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 19, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 19, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 19, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, May 8, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, May 8, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, December 12, 2014REFUSAL PROCESSED BY IB
Monday, November 24, 2014NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, November 24, 2014REFUSAL PROCESSED BY MPU
Friday, November 21, 2014NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, November 20, 2014NON-FINAL ACTION WRITTEN
Tuesday, November 18, 2014APPLICATION FILING RECEIPT MAILED
Friday, November 14, 2014ASSIGNED TO EXAMINER
Friday, November 14, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 13, 2014SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

trilexium cancer treatment therapeutic pharmaceutical medical preparations drugs agents anti